Skip to main content

Program

Scientific program

The scientific program “Preparing for the future” will showcase the latest developments in clinical chemistry. We aim to cover state-of-the-art knowledge in a wide variety of fields of clinical chemistry bridging basic research and clinical application, and spanning from practical issues in daily routine to advanced data science. New technological developments as well as requirements to prepare for a future successful career in clinical chemistry will be covered. Our invited plenary speakers provide cutting edge updates with an in-depth focus on cardiometabolic disease, coagulation and neurodegenerative disease. We expect that our ambitious program will fulfill the needs of virtually everybody working in and around the exciting field of clinical chemistry.

Development and Improvements

For the XXXIX Nordic Congress in Clinical Chemistry, we are excited to present a new topic “Development and Improvements” as a complement to the scientific program. This topic fosters collaboration among professionals from various disciplines, including clinical chemists, laboratory technicians, biomedical scientists, researchers, and healthcare providers to shed light upon intriguing subjects.    

Key features and components of the area include:

  • Advances in the area Artificial Intelligence (AI) and the future of laboratories.
  • Diversity and inclusion in laboratory professions and opportunities for career growth.
  • Evolving skill sets (task-shifting) and competencies required for careers in future laboratories.
  • Healthy and sustainable workplace-environments.
  • Examples and lessons learned from laboratories during times of crisis.

There is an immense anticipation for the XXXIX Nordic Congress in Clinical Chemistry and by addressing these topics, the congress can foster dialogue, collaboration, and knowledge sharing among stakeholders involved in shaping the future of laboratories. It can also promote innovation and resilience in laboratories to address a wide range of challenges, from scientific breakthroughs to crises like pandemics. Hope to see you in the beautiful city of Stockholm soon!

Welcome to take part of four inspiring days in Stockholm. The scientific program will be continously updated.


  • 
    

    Tuesday 17 September 2024

    12:30 Opening ceremony and Welcome
    12:45

    Plenary session on Cardiovascular disease : Lipid profile and cardiovascular disease

    Chair:  U Tietge (Sweden)

     Prof. B G. Nordestgaard (Denmark)

    13:30 Break
    13:45

    The Lorentz Eldjarn Prize Competition for Best Publication

    Prof. J P Berg, Managing Editor of SJCLI (Norway) 

    The three nominated authors will present their articles

    The price ceremony will be held at the congress dinner on Thursday at the Vasa museum

    15:15 Coffee & Exhibition
    15:30

    Clinical chemistry through the ages: milestones, discoveries and innovations

    Chair: H Dahl (Sweden)

    Assoc Prof. A Kallner  (Sweden)

    Prof. K Pulkki (Finland)

    Kidney function measurement – what is needed in clinical practice?

    Chair: U Tietge (Sweden)

    Prof. M de Borst (The Netherlands) Kidney function: glomerular filtration rate and beyond

    PhD MD P Delanaye (Belgium)

    Session by NFKK: Recommendations from The Nordic preanalytical scientific working group

    Chair: M Nybo (Denmark)

    Prof. Dr. J Cadamuro (Austria) Progress in Europe on the preanalytical area?

    Clin Biochemist PhD J Pelanti (Finland) How do we use pneumatic tube systems in the Nordic countries?

    Lecture PhD B Willman (Sweden) Survey on Nordic blood sampling recommendation/status for blood sampling QC

    PhD G B Berge Kristensen (Norway) Recommendation on how to handle hemolysis indices

    Assoc prof. M Nybo (Denmark) Nordic fasting recommendation – how to proceed?
     

    17:15 -  Poster reception and mingle in Aula Medica
  • Wednesday 18 September

    07:30  

    Educational session

    Hematology – selected case discussion

    PhD MD S Beshara (Sweden)

    Educational session

    Hot debate - Pros and cons of large-scale screening

    PhD MD N Bark (Sweden)

    08:15 Break
    08:30

    Nordic screening and testing programs

    Chairs: L Franzon (Iceland) & P Bjellerup (Sweden)

    Prof. S Y Kristinsson (Iceland) Screening for monoclonal gammopathy of undetermined significance: a nationwide randomized clinical trial

    Prof. O Bratt (Sweden) Outcome of organised PSA testing in Sweden - Is there enough benefit?

    Erythrocyte disorders

    Chair: S Beshara (Sweden)

    Prof. A Iolascon (Italy) New insight in red cell membrane disorders: diagnosis and treatment

    PhD MD O Klingenberg (Norway)

    PhD MD S Beshara (Sweden)

    MSc A Lundholm (Sweden)

    Predicting the unpredictable? Novel developments to personalize healthcare

    Chair: P Parini (Sweden)

    Prof. S Meijer (Sweden)

    Prof. M Benson (Sweden) Digital twins of individuals for predictive, preventive and personalised medicine

    10:00 Coffee & Exhibition
    10:30

    Serum biomarkers for diagnosing cancer – where do we stand today?

    Chair: M Hansson (Sweden)

    PhD MD Nome (Norway)

    Alcohol and drug testing - new substances and new analytical problems

    Chair: G Eggersten (Sweden)

    Assoc Prof. A Helander (Sweden)

    Transfer of PFAS from the mother and associated metabolic and neurodevelopmental changes in the child

    Chair: I Hokstad (Norway)

    PhD MD A Bjørke Monsen (Norway) 

    11:00 Break
    11:15

    The Margareta Blombäck plenary session on Coagulation: Thrombotic Microangiopathies (TMA) - many diseases not so many tests- Special Focus om Preeclampsia 

    Chair: Prof. J Antovic (Sweden)

     Prof. V Garovic  (USA) 

    12:00 12:00-13:45  Lunch & Exhibition
    12:30 Company session Company session Company session
    13:00 12:00-13:45  Lunch & Exhibition
    13:45

    Laboratory Medicine in times of crisis

    Chair: M Lambert (Sweden)

    Médecins Sans Frontières 

    MD C Tosterud (Sweden)  - Healthcare during war

    Thrombotic microangiopathies - many diseases not so many tests

    Chair: J Antovic (Sweden)

    Prof. J Antovic (Sweden) New approaches in the laboratory diagnosis of HUS/TTP

    PhD mD M Farm (Sweden) Laboratory role in the diagnosis and follow up the treatment in HIT

    MD A Kimiaei (Sweden) Implementing the ISTH guidelines for the diagnosis of lupus anticoagulant - our experience and lessons learned

     

    Session by Institutet för biomedicinsk laboratorievetenskap

    Chair: S Kronberg (Sweden) and M Quttineh (Sweden)

    Assoc Prof. G Lillsunde Larsson (Sweden) 70 years with the International Federation of Biomedical Science (IFBLS)

    Biomed lab scientist Å Gyberg-Karlsson (Sweden) : Future developments in biomedicine and health with the potential to impact our profession (and the society)

    Assoc Prof. G Lillsunde Larsson (Sweden) Actionplan for the Future- the situation for biomedical laboratory scientists in Denmark, Finland, Norway, and Sweden

    15:15 Coffee & Exhibition
    15:45

    Healthy Workplaces, Healthy Workers: Tips and Tricks for Lab Pros

    Chair: A Dahlin (Sweden)

    RN. CCN. MSc. M Flodberg (Sweden)

    Å Malmenklev (Sweden)

    S Lööv (Sweden)

    New targets, new opportunities? Cardiovascular biomarkers today and tomorrow

    Chair: U Tietge (Sweden)

    Prof. U Tietge (Sweden)

    Liver diseases - an expanding medical field

    Chair: M Hansson (Sweden)

    Dr. M van Berkel (Netherlands)

    Adjunct Prof. H Hagström (Sweden) Diagnosis and prognosis of steatotic liver disease

    17:15 End of day

    Thursday 19 September

    07:30

    Educational session

    Dyslipidemia – selected case discussion

    Prof. G Eggertsen (Sweden)

    Educational session

    Coagulation

    PhD MD M Farm (Sweden)

    Educational session

    New aspects on Vitamin B12 and folate deficience and the toxic effect of laughin gas

    Assoc Prof. H Nilsson Ehle (Sweden)

    08:15 Break
    08:30

    Improvement and development

    ChairA Linko-Parvinen (Finland)

    Assoc Prof. T Männistö (Finland) Hypothyroidism is increasing – is it true or overdiagnosis

    Assoc Prof. S Wittfooth (Finland) Recent developments in troponin assays

    AI - the future colleague in clinical chemistry

    Chair: P Parini (Sweden)

    Dr. G Menichetti (USA)

    Assoc Prof. N Fyhrquist (Sweden)

    Session by the Swedish Association of Clinical Biochemists - Clinical importance of measurements of low levels of sex hormones

    Chair: A Engberg (Sweden)

    Prof. A Lindén Hirschberg (Sweden)  

    Assoc Prof. H Ryberg (Sweden) High-sensitive mass spectrometric assays for androgens and estrogens in the clinical lab

    10:00 Coffee & Exhibition
    10:30

    Mass is King - Novel mass spectrometric applications in clinical chemistry

    Chair: L Tjernberg (Sweden)

    Prof. J Lehtiö (Sweden) Proteomics for diagnosing disease

    PhD S Gaunitz (Sweden) Glycomics at Clinical chemistry

    Navigating Clinical Laboratory Values in the Era of CAR-T and CAR-NK Cell Therapy: Challenges and Opportunities

    Assoc Prof. E Alici (Sweden)

    What clinical chemists should know about the interpretation of blood tests in transgender individuals

    Prof. M den Heijer (Netherlands)

    11:00 Break
    11:15

    Plenary session on Neurodegenerative disease:  Fluid biomarkers for Alzheimer’s – finding the place of blood and CSF tests at the memory clinic and in the clinical chemistry lab

    Chair: L Tjernberg (Sweden)

    Prof. K Blennow  (Sweden) 

    12:00 12:00-13:45  Lunch & Exhibition
    12:30 Company session Company session organised by Roche
    Step into the future with cobas Mass Spec analyzer, i601
    Company session
    13:00 12:00-13:45  Lunch & Exhibition
    13:45

    How paradigm shifts shape the future of laboratory medicine

    Chair: I Bartuseviciene (Sweden)

    Assoc Prof. P Conner (Sweden) Prenatal paradigm

    External quality assessment in laboratory medicine: what, how and why

    Chairs: L Spendrup & M Johansson (Sweden)

    Assoc Prof. L Björndahl (Sweden) How new standards are developed – the professions can be in charge

    Blood biomarkers - A new era for diagnosing Alzheimer disease?

    Chair: L Tjernberg (Sweden)

    Dr. T Karikari (Sweden) pTau variants predict disease

    Assoc Prof. S Schedin Weiss (Sweden) Glycans as novel biomarkers for Alzheimer disease

    Prof. L Jönsson (Sweden) Can we justify screening for Alzheimer disease?

    Laboratory and cancer associated thrombosis (CAT) - where we are

    Chair: J Antovic (Sweden)

    Prof. A Falanga (Italy) CAT overview

    Prof. J Odeberg (Sweden) Proteomics in CAT

    PhD MD C Gran (Sweden) Extracellular Vesicles, Tissue Factor, and NETosis

    15:15 Coffee & Exhibition
    15:45

    External quality assessment in laboratory medicine: what, how and why

    Chairs: L Spendrup & M Johansson (Sweden)

    BSc Å Claesson (Sweden) The significance of accreditation for the laboratory

    MSc M Dajaku (Sweden) Differences between ISO 15189:2012 and ISO 15189:2022

    Precision medicine: dream or reality?

    Chair: P Parini (Sweden)

    Prof. P Parini (Sweden)

    Assoc Prof. Å Wheelock (Sweden)

    Session by BALM

    Chair: U Tietge (Sweden)

    PhD MD V Banys (Lithuania) & M Bieliauskas (Lithuania) Roadtrip towards harmonized reporting of laboratory results in Lithuania. 

    MD J Meisters (Latvia) 

    PhD A Tamm (Estonia) Digital transmission of laboratory data in Estonia. 

    17:15 End of program
  • Friday 20 September

    07:30

    Educational session

    Brain calcification – selected case discussion

    Assoc Prof. U Diczfalusy (Sweden)

    Educational session - Analytical interference in Clinical chemistry 

    MD PhD P Bjellerup (Sweden)

    MD M Karlman (Sweden)

    08:15 Break
    08:30

    The future of laboratories: trends, challenges and opportunities

    Chair: G Dahlfors (Sweden)

    PhD B Schadenberg (Holland)

    Biomed lab scientist L Nyman (Sweden)

    Career and competence in laboratory medicine: challenges, trends and best practices

    Session in Swedish

    Chair: M Shafaati Lambert (Sweden)

    BSc N Hourani Soutari (Sweden) -Integrerad forskning och kliniskt arbete               

    MSc H Stenling (Sweden) - Norrtäljeprojektet

    Biomed lab scientist A Collberg (Sweden) -  Runda Bordet

    BSc M Kjellén & BSc J Borrman (Sweden) - Kompetensväxling vid proteinbedömningar 

    Session by Svensk Förening för Klinisk Kemi -

    Using labs wisely – laboratory medicine in an era of choosing wisely. 

    Chair:  J Skogö (Sweden)

    Prof. K Stordal (Norway)

    MD K Bengtsson Linde (Sweden)

    10:00 Coffee & Exhibition
    10:30

    The NFKK Young Scientist Award 

    Prof. MD LM Rasmussen (Denmark)

    The three awarded will present their scientific work

    12:00 Lunch Break
    12:30 Plenary session by Nordisk Forening for Klinisk Kemi - Clinical metabolomics, a new era for laboratory medicine:
    Chairs: P Bjellerup (Sweden) and Y T Bliksrub (Norway)

    PhD Msc K Elgstøen (Norway) Global metabolomics, why and how

    Prof. R M A Heeren (Netherlands)

    PhD MD  Y T Bliksrud (Norway) Interpretation challenges, the need for the medical doctor in the laboratory  

    13:15-14:00 Closing ceremony with presentation of NFKK young scientist award and welcome to NCCC2026 Århus, Denmark
    14:00 End of the Conference